PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatme
Go back to PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatme(NASDAQ: PRTC) | Delayed: 26.94 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $26.94 | 52 Week High | $ | |||
Open | $26.94 | 52 Week Low | $ | |||
Day High | $26.94 | P/E | N/A | |||
Day Low | $26.94 | EPS | $ | |||
Volume | 228 |
(NASDAQ: PRTC) | Delayed: 26.94 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $26.94 | 52 Week High | $ | |||
Open | $26.94 | 52 Week Low | $ | |||
Day High | $26.94 | P/E | N/A | |||
Day Low | $26.94 | EPS | $ | |||
Volume | 228 |